Skip to content

Longevity Health Holdings, Inc.: 10-Q filed 2023-08-14

What Longevity Health Holdings, Inc. reported in its quarterly report filed 2023-08-14 (fiscal Q2 2023): 15 published measures, 46 facts as tagged in accession 0001193125-23-212538.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-14
Fiscal period
fiscal Q2 2023
Accession
0001193125-23-212538 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Longevity Health Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-30160,300,925USD
At 2022-12-31156,978,800USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-304,110,061USD
At 2022-12-317,086,950USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-30-2,402,459USD
At 2023-03-31-1,307,641USD
At 2022-12-31-6,017,679USD
At 2022-06-30-5,644,396USD
At 2022-03-31-5,297,410USD
At 2021-12-31-4,762,268USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30317,511USD91
2023-01-01 to 2023-06-30893,578USD181
2023-01-01 to 2023-03-31576,067USD90
2022-04-01 to 2022-06-30-346,986USD91
2022-01-01 to 2022-06-30-874,516USD181
2022-01-01 to 2022-03-31-527,530USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-177,421USD181
2022-01-01 to 2022-06-30-194,910USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-2,402,891USD
At 2022-12-31-6,018,111USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-04-01 to 2023-06-30388,625USD91
2023-01-01 to 2023-06-30731,953USD181
2022-04-01 to 2022-06-30266,406USD91
2022-01-01 to 2022-06-30266,406USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1,161,478USD91
2023-01-01 to 2023-06-30-1,917,944USD181
2022-04-01 to 2022-06-30-285,876USD91
2022-01-01 to 2022-06-30-821,018USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-3064,431USD
At 2022-12-31285,202USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-304,110,061USD
At 2022-12-311,681,514USD

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-06-3010,243USD
At 2022-12-31187,664USD
At 2022-06-30551,497USD
At 2021-12-31774,192USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-300USD
At 2022-12-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-06-302,815,180USD
At 2022-12-311,258,337USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-30706,136USD91
2023-01-01 to 2023-06-301,625,531USD181
2022-04-01 to 2022-06-30-80,580USD91
2022-01-01 to 2022-06-30-608,110USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-01-01 to 2023-06-30893,578USD181
2022-01-01 to 2022-06-30-874,516USD181

Inspect the source

Entity
Longevity Health Holdings, Inc. / CIK 0001842939
Captured
2026-09-21T17:37:49.979Z
SEC response SHA-256
33db7095b2d5ec482c7a1d00924c3102d456f2ff5cede2f410122a82954c4d25

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001842939.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))